Search by Drug Name or NDC
NDC 51754-2004-04 Potassium Acetate 200 meq/100mL Details
Potassium Acetate 200 meq/100mL
Potassium Acetate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is POTASSIUM ACETATE.
Product Information
| NDC | 51754-2004 |
|---|---|
| Product ID | 51754-2004_2b86b9e8-48ba-4a72-b705-48c2751016e6 |
| Associated GPIs | |
| GCN Sequence Number | 001241 |
| GCN Sequence Number Description | potassium acetate VIAL 2 MEQ/ML INTRAVEN |
| HIC3 | C1D |
| HIC3 Description | POTASSIUM REPLACEMENT |
| GCN | 03212 |
| HICL Sequence Number | 000546 |
| HICL Sequence Number Description | POTASSIUM ACETATE |
| Brand/Generic | Generic |
| Proprietary Name | Potassium Acetate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Potassium Acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | meq/100mL |
| Substance Name | POTASSIUM ACETATE |
| Labeler Name | Exela Pharma Sciences, LLC |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206203 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51754-2004-04 (51754200404)
| NDC Package Code | 51754-2004-4 |
|---|---|
| Billing NDC | 51754200404 |
| Package | 25 VIAL, GLASS in 1 CARTON (51754-2004-4) / 100 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2023-08-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |